Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
The New England Journal of Medicine|April 5, 2019
Heart and Lung Transplants from HCV-Infected Donors to Uninfected RecipientsAnn E Woolley, Steve K Singh, Hilary J Goldberg, et al.Inquiry : a Journal of Medical Care Organization, Provision and Financing|December 26, 2023
Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost AnalysisTeryl K Nuckols, Carl T Berdahl, Andrew J Henreid, et al.The American Journal of Medicine|May 5, 2020
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action InitiativeEbrahim Barkoudah, Gregory Piazza, Todd E H Hecht, et al.JAMA|September 15, 2025
Superficial Vein Thrombosis: A ReviewGregory Piazza, Darsiya Krishnathasan, Nada Hamade, et al.The American Journal of Medicine|May 29, 2023
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time PeriodsJohn Fanikos, Yahya Tawfik, Danya Almheiri, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2013
Venous thromboembolic diseaseMichael B Streiff, Paula L Bockenstedt, Spero R Cataland, et al.Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.Journal of the American College of Cardiology|October 15, 2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art ReviewAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.Contemporary Clinical Trials|May 1, 2021
The Pharmacist Discharge Care (PHARM-DC) study: A multicenter RCT of pharmacist-directed transitional care to reduce post-hospitalization utilizationJoshua M Pevnick, Michelle S Keller, Korey A Kennelty, et al.Thrombosis Research|June 11, 2023
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network studyBehnood Bikdeli, Candrika D Khairani, Darsiya Krishnathasan, et al.Pageof 13